Oncotarget: определение коамплификаций онкогенов HER при раке груди

Oncotarget недавно опубликовал статью « Совместная работа для семьи: определение коамплификаций онкогенов HER при раке груди », в которой сообщается, что, несмотря на специфическое лечение, к сожалению, у 20% первичных и 70% метастатических опухолей HER2 развивается резистентность. Кроме того, авторы разработали протокол, основанный на комбинации MLPA с ddPCR для определения доли коамплифицированных HER в опухоли. На 111 IDC результаты HER2 MLPA были подтверждены FISH, CISH и IHC. Процент клеток с коамплифицированным HER2 варьировал среди опухолей. Независимые результаты in-silico показывают, что исход пациентов с HER2 обусловлен статусом HER3 и HER4. В Oncotarget результаты автора стимулировать дальнейшие исследования для изучения взаимосвязи с ответом пациента на одного или комбинированное лечение.

Комментарии

Отправить комментарий

Популярные сообщения из этого блога

New Synergistic Method of Treatment for Select Lymphomas

A team of scientists from Columbia University Medical Center has formulated a new, synergistic method of potential treatment for patients with mantle cell lymphoma. Mantle cell lymphoma (MCL) is an aggressive and currently incurable cancer of the white blood cells, with an average survival rate of only a few years. The goal of this new study is to develop a better treatment that increases the length and quality of life for patients suffering with MCL. Researchers from Columbia University Medical Center in New York City have recently published the research paper in Oncotarget, an open-access scientific journal, detailing their study to develop this new potential treatment method for patients with MCL. Philadelphia hospital San Antonio hospitals San Diego hospitals New Synergistic Treatment Combination for MCL Histone deacetylation (HDAC) inhibitors are commonly used as anti-cancer drugs and considered highly effective in the treatment of select lymphomas. The team used the HDA...
Далее...

MRI and ADC Histogram Analysis in Lymphoma Treatment

Study demonstrates that MRI and DWI of patient samples with primary central nervous system lymphoma can be used to predict and monitor disease progression through the use of ADC histogram analysis of Ki-67 expression. oncotarget research Virus cells under the microscope isolated on white background. Scientists have long been aware that lymphoma occurs when multiple genetic changes take place in the white blood cells. This causes the white blood cells to grow out of control and no longer respond to central signaling—which would stop them from overgrowing and aid in natural cell death. However, many other factors driving lymphoma diagnosis have not been fully illuminated. “Primary central nervous system lymphoma (PCNSL) is a rare subgroup of non-Hodgkin lymphoma confined to the central nervous system, with more than 90% of cases classified as Diffuse Large B-cell Lymphoma [1, 2].” “Oncotarget” In a paper published in Oncotarget, researchers from the United States’ Texas, Missouri,...
Далее...

hospitals in us

Изображение
When people speak of today’s medicine, precision plays one of the most significant roles and human lives are directly dependent on it. Hence, any researches pertaining to medicine are required to comply with the top standards. The issue nowadays is that any recommendations of researches can be posted online and used as a reference without being adequately verified and validated. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this challenge and tried to come up with an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been founded back in 2010. The key principle of this journal is related to Altmetric scores that are used as a quality indicator. That allows both readers and authors to quality-check publications with Altmetric Article Reports that create “real-time feedback containing data summary related to a particular publication. ” Oncotarget website demonstrates a complete publications list with respective scores h...
Далее...